ANGIOTENSIN II


ArtNr	18-783-77314
Hersteller	GENWAY
Menge	1 ml
Kategorie	Oncology Antibodies ELISA Cardiovascular Research Heart Failure Myocardial Infarction Hypertension Primary Antibodies By Organ Lung Cancer
Typ	Antibody
Applikationen	ELISA
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-31E10F
Similar products	18-783-77314
Lieferbar
Genway ID:	GWB-31E10F
Specificity:	ANGIOTENSIN II
Specificity:	ANGIOTENSIN II
Immunogen:	RSA/RaIg conjugated
Specificity Note:	This product is specific for Angiotensin II and shows the following cross-reactivities with other forms of Angiotensin:Angiotensin III 75%Angiotensin I 20% Angiotensin II is formed by cleavage of the terminal two amino acid residues of Angiotensin I by ACE (Angiotensin-converting enzyme). It is mainly found in lung capillaries where it increases blood pressure before being degraded to Angiotensin III by cleavage of the N-terminal aspartic acid residue.
Preparation:	Ig fraction prepared by ammonium sulphate precipitation
Buffer Solution:	Phosphate buffered saline pH 7. 2
Preservative Stabilisers:		0. 09% Sodium Azide (NaN3) 1% Bovine Serum Albumin Summary: The protein encoded by this gene pre-angiotensinogen or angiotensinogen precursor is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product angiotensin I is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Summary: The protein encoded by this gene pre-angiotensinogen or angiotensinogen precursor is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product angiotensin I is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension and can cause renal tubular dysgenesis a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation and inflammatory bowel disease. [provided by RefSeq].

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 1 ml

lieferbar

Lieferung vsl. bis 11.09.2025